EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Modeling human cancer predisposition syndromes using CRISPR /Cas9 in human cell line models

Garrett M Draper iD, Daniel J Panken, David A Largaespada

Genes, Chromosomes and Cancer · 2023

DOI: 10.1002/gcc.23140 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Genes, Chromosomes and Cancer, 2023. Verfasst von Garrett M Draper und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, University of Minnesota Twin Cities, Minneapolis, USA. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The advancement of CRISPR mediated gene engineering provides an opportunity to improve upon preclinical human cell line models of cancer predisposing syndromes. This review focuses on using CRISPR/Cas9 genome editing tools to model various human cancer predisposition syndromes. We examine the genetic mutations associated with neurofibromatosis type 1, Li‐Fraumeni syndrome, Gorlin syndrome, BRCA mutant breast and ovarian cancers, and APC mutant cancers. Furthermore, we discuss the possibilities of using next‐generation CRISPR‐derived precision gene editing tools to introduce a variety of genetic lesions into human cell lines. The goal is to improve the quality of preclinical models surrounding these cancer predisposition syndromes through dissecting the effects of these mutations on the development of cancer and to provide new insights into the underlying mechanisms of these cancer predisposition syndromes. These studies demonstrate the continued utility and improvement of CRISPR/Cas9‐induced human cell line models in studying the genetic basis of cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CRISPR-Cas SystemsNeoplasmsHumansSyndromeGene EditingDisease SusceptibilityCell Line

Stichwörter der Autor:innen

CRISPRiPSCmodels

Autor:innen und Institutionen

  • Department of Pediatrics, University of Minnesota Twin Cities, Minneapolis, USA.
  • Comparative Molecular Biosciences PhD Program, University of Minnesota Twin Cities, Minneapolis, USA.

ORCID-Profile: Garrett M Draper

Förderung

  • NINDS NIH HHS
  • NCI NIH HHS

Zitieren

APA

Draper, G. M., Panken, D. J., & Largaespada, D. A. (2023). Modeling human cancer predisposition syndromes using CRISPR /Cas9 in human cell line models. Genes, Chromosomes and Cancer. https://doi.org/10.1002/gcc.23140

Vancouver

Draper GM, Panken DJ, Largaespada DA. Modeling human cancer predisposition syndromes using CRISPR /Cas9 in human cell line models. Genes, Chromosomes and Cancer. 2023. doi:10.1002/gcc.23140

BibTeX
@article{Draper2023,
  author = {Draper, Garrett M and Panken, Daniel J and Largaespada, David A},
  title = {Modeling human cancer predisposition syndromes using CRISPR /Cas9 in human cell line models},
  journal = {Genes, Chromosomes and Cancer},
  year = {2023},
  doi = {10.1002/gcc.23140}
}
Kostenlos starten →